The Ensign Group Inc is a medical care facilities business based in the US. The Ensign Group shares (ENSG) are listed on the NASDAQ and all prices are listed in US Dollars. The Ensign Group employs 24,400 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Long-term investors
Our top pick for
Beginners
Our top pick for
Active traders
| Latest market close | $75.52 |
|---|---|
| 52-week range | $68.25 - $98.42 |
| 50-day moving average | $80.47 |
| 200-day moving average | $82.16 |
| Wall St. target price | $93.40 |
| PE ratio | 23.7327 |
| Dividend yield | $0.21 (0.27%) |
| Earnings per share (TTM) | $3.39 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $75.52 from 2022-01-21
| 1 week (2022-01-13) | -5.93% |
|---|---|
| 1 month (2021-12-21) | -5.76% |
| 3 months (2021-10-22) | 4.67% |
| 6 months (2021-07-22) | -10.95% |
| 1 year (2021-01-22) | -11.34% |
|---|---|
| 2 years (2020-01-22) | 58.89% |
| 3 years (2019-01-22) | 83.45% |
| 5 years (2017-01-20) | 272.87% |
Valuing The Ensign Group stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of The Ensign Group's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
The Ensign Group's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 24x. In other words, The Ensign Group shares trade at around 24x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
The Ensign Group's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.3473. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into The Ensign Group's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
The Ensign Group's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $304.4 million.
The EBITDA is a measure of a The Ensign Group's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $2.6 billion |
|---|---|
| Operating margin TTM | 9.78% |
| Gross profit TTM | $420.2 million |
| Return on assets TTM | 5.94% |
| Return on equity TTM | 22.34% |
| Profit margin | 7.5% |
| Book value | $17.90 |
| Market capitalisation | $4.4 billion |
TTM: trailing 12 months
Dividend payout ratio: 6.16% of net profits
Recently The Ensign Group has paid out, on average, around 6.16% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.27% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), The Ensign Group shareholders could enjoy a 0.27% return on their shares, in the form of dividend payments. In The Ensign Group's case, that would currently equate to about $0.21 per share.
While The Ensign Group's payout ratio might seem low, this can signify that The Ensign Group is investing more in its future growth.
The Ensign Group's most recent dividend payout was on 30 January 2022. The latest dividend was paid out to all shareholders who bought their shares by 29 December 2021 (the "ex-dividend date").
The Ensign Group's shares were split on a 1069:1000 basis on 30 September 2019. So if you had owned 1000 shares the day before before the split, the next day you'd have owned 1069 shares. This wouldn't directly have changed the overall worth of your The Ensign Group shares – just the quantity. However, indirectly, the new 6.5% lower share price could have impacted the market appetite for The Ensign Group shares which in turn could have impacted The Ensign Group's share price.
Over the last 12 months, The Ensign Group's shares have ranged in value from as little as $68.2458 up to $98.417. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while The Ensign Group's is 0.96. This would suggest that The Ensign Group's shares are less volatile than average (for this exchange).
The Ensign Group, Inc. provides skilled nursing, senior living, and rehabilitative services. It operates in two segments, Transitional and Skilled Services and Real Estate. The company offers transitional and skilled services, which include short and long-term nursing care services for patients with chronic conditions, prolonged illness, and the elderly; and physical, occupational, and speech therapies and other rehabilitative and healthcare services. It also provides standard services, such as room and board, special nutritional programs, social, recreational, entertainment, and other services. In addition, the company offers senior living, as well as mobile diagnostics services; leases real estate properties; and provides other ancillary services consisting of digital x-ray, ultrasound, electrocardiogram, laboratory, sub-acute, and patient transportation services to people in their homes or at long-term care facilities. As of January 4, 2022, it operated 246 healthcare facilities in Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, South Carolina, Texas, Utah, Washington, and Wisconsin.
Melania Trump launched an NFT platform — you can buy an image of her eyes.
Read our expert analysis on Vigorus and how the token will perform in the future.
While there are no known plans to expand the acceptance of Doge to its cars, customers can already buy a Tesla with Bitcoin.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
Monie offers 5% APY on deposits, but funds aren’t insured and the interface is buggy.
We’ve rounded up stats on some of the most popular COVID test stocks, along with information on how they compare and how to invest.
Buffett’s Berkshire Hathaway may now be on its way to becoming the next trillion-dollar company.
Record vehicle deliveries cause the Tesla stock price to move close to all-time highs.
Everything we know about the Affinia Therapeutics IPO, plus information on how to buy in.
Everything we know about the Austin Gold IPO, plus information on how to buy in.